For decades , clinicians have searched for viable solutions for treatment-resistant mood disorders. Recently suggests copyright therapy, given typically intravenously , appears to offer real opportunity for individuals who haven't seen results from conventional antidepressants . Though primarily considered a developing intervention, initial finding